Prostate Cancer Analysis
🌏 NMPAExpert commentary and market intelligence for pharma strategy teams
Showing 1–2 of 2 articles
Earlier
High impact AnalysisJun 2, 2026
Minghui and Qilu Pharmaceutical Unveil Promising MHB088C Data in mCRPC at ASCO 2026
mCRPC · 8 min
Dr. Yuki TanakaHigh impact AnalysisApr 21, 2026
Radioligand Therapies for Prostate Cancer: Market Access and Clinical Insights in APAC
NMPA · oncology · 12 min
Dr. Yuki TanakaExplore intelligence